(Q43779961)

26 November 2017

title

Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey (English)

1 reference

26 November 2017

5

Veikko Salomaa

1 reference

26 November 2017

3

Aki S Havulinna

1 reference

26 November 2017

4

Pekka Jousilahti

1 reference

26 November 2017

Hanna-Riikka Lehto

1

1 reference

26 November 2017

Seppo Lehto

series ordinal

2

1 reference

26 November 2017

publication date

2 September 2011

1 reference

European Journal of Preventive Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

19

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

1153-1160

1 reference

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Are coronary event rates declining slower in women than in men - evidence from two population-based myocardial infarction registers in Finland?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Gender differences in trends of acute myocardial infarction events: the Northern Sweden MONICA study 1985 - 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Thirty-five-year trends in cardiovascular risk factors in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Management of cardiovascular risk factors in people with diabetes in primary care: cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Physicians' perception of guideline-recommended low-density lipoprotein target values: characteristics of misclassified patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711422454

21 January 2018

Identifiers

DOI

10.1177/1741826711422454

1 reference

26 November 2017

1 reference